Related references
Note: Only part of the references are listed.The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy' - implications for pre-clinical research and drug testing
Lidia Anguiano Gomez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome
Viji Nair et al.
KIDNEY INTERNATIONAL (2018)
Reproductive health and pregnancy in women with chronic kidney disease
Kate S. Wiles et al.
NATURE REVIEWS NEPHROLOGY (2018)
Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study
Toshiki Iwai et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
James Voelker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Complications of Diabetes Diagnosed in Children and Adolescents In Reply
Dana Dabelea et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Assessment of Global Kidney Health Care Status
Aminu K. Bello et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE
Xiaoxin X. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Predictors for the development of microalbuminuria and interaction with renal function
Christos Chatzikyrkou et al.
JOURNAL OF HYPERTENSION (2017)
A more tubulocentric view of diabetic kidney disease
Letizia Zeni et al.
JOURNAL OF NEPHROLOGY (2017)
Targeting mTOR Signaling Can Prevent the Progression of FSGS
Stefan Zschiedrich et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
Lennart Tonneijck et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Adeera Levin et al.
LANCET (2017)
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
Weier Qi et al.
NATURE MEDICINE (2017)
Kidney disease and obesity: epidemiology, mechanisms and treatment
Niels Olsen Saraiva Camara et al.
NATURE REVIEWS NEPHROLOGY (2017)
MP393LONG-TERM SAFETY AND EFFECTIVENESS OF ECULIZUMAB FOR PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: OUTCOMES FROM A PROSPECTIVE OBSERVATIONAL CLINICAL TRIAL
Jan Menne et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Differences in acute kidney injury ascertainment for clinical and preclinical studies
Marco Fiorentino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Single-Nephron Glomerular Filtration Rate in Healthy Adults
Aleksandar Denic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012
Elizabeth J. Mayer-Davis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
Sophia Zoungas et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Chronic kidney disease
Paola Romagnani et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease
Carol Pollock et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function
Thati Madhusudhan et al.
BLOOD (2017)
Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD
Sankar D. Navaneethan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy
Wilhelm Kriz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Vascular endothelium in diabetes
Michael S. Goligorsky
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Risk Factors for Severe Bleeding Complications in Percutaneous Renal Biopsy
Da-min Xu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Innate immunity in diabetes and diabetic nephropathy
Jun Wada et al.
NATURE REVIEWS NEPHROLOGY (2016)
CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes
Beina Teng et al.
DIABETES (2016)
Targeting inflammation in diabetic kidney disease: early clinical trials
Maria Vanessa Perez-Gomez et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases
Shujun Liu et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Hurdles to the introduction of new therapies for immune-mediated kidney diseases
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2016)
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
Vivette D. D'Agati et al.
NATURE REVIEWS NEPHROLOGY (2016)
Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
Daniel Fantus et al.
NATURE REVIEWS NEPHROLOGY (2016)
Cardiac and Renovascular Complications in Type 2 Diabetes - Is There Hope?
Julie R. Ingelfinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nephron Protection in Diabetic Kidney Disease
Hans-Joachim Anders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Yuan-ye Qiu et al.
PHARMACOLOGICAL RESEARCH (2016)
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
Volker Vallon
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Genetics of Diabetic Nephropathy: a Long Road of Discovery
Amy Jayne McKnight et al.
CURRENT DIABETES REPORTS (2015)
Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients
Thomas Wilke et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys
Xuezhu Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2015)
Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus
Gudeta D. Fufaa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
Thati Madhusudhan et al.
NATURE COMMUNICATIONS (2015)
Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China
Qiang Wan et al.
JOURNAL OF DIABETES (2015)
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
Dick de Zeeuw et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Epigenetic mechanisms in diabetic complications and metabolic memory
Marpadga A. Reddy et al.
DIABETOLOGIA (2015)
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
Jia Fu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
A. Sharif et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.
Ching-Wei Tsai et al.
DIABETES CARE (2014)
Is diabetic nephropathy reversible?
Paola Fioretto et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes The Hoorn Study
Thomas T. van Sloten et al.
HYPERTENSION (2014)
Improved Glycemic Control and Risk of ESRD in Patients with Type 1 Diabetes and Proteinuria
Jan Skupien et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Pattern recognition receptors and the inflammasome in kidney disease
Jaklien C. Leemans et al.
NATURE REVIEWS NEPHROLOGY (2014)
Changes in Diabetes-Related Complications in the United States, 1990-2010
Edward W. Gregg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress
Florian Grahammer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes
Shree G. Sharma et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Podocyte Mitosis - A Catastrophe
L. Lasagni et al.
CURRENT MOLECULAR MEDICINE (2013)
Identification of Cross-Species Shared Transcriptional Networks of Diabetic Nephropathy in Human and Mouse Glomeruli
Jeffrey B. Hodgin et al.
DIABETES (2013)
Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes
E. Jennifer Weil et al.
DIABETES (2013)
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
X. Zhong et al.
DIABETOLOGIA (2013)
Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases
Li Zhuo et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
Fabian Bock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Significance of renal biopsy in patients with presumed diabetic nephropathy
Koji Harada et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Diabetic nephropathy: Is it time yet for routine kidney biopsy?
Maria L. Gonzalez Suarez et al.
WORLD JOURNAL OF DIABETES (2013)
Clinical implications of pathologic diagnosis and classification for diabetic nephropathy
Se Won Oh et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Glomerular hyperfiltration: definitions, mechanisms and clinical implications
Imed Helal et al.
NATURE REVIEWS NEPHROLOGY (2012)
Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes
Nicole Stieger et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical Predictors of Non-diabetic Renal Disease and Role of Renal Biopsy in Diabetic Patients with Renal Involvement: A Single Centre Review
Yip-Boon Chong et al.
RENAL FAILURE (2012)
Non-diabetic renal disease in patients with type-2 diabetes mellitus
Sonia Yaqub et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2012)
Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice
Ming-Zhi Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Albuminuria and Estimated Glomerular Filtration Rate as Predictors of Diabetic End-Stage Renal Disease and Death
Abeba M. Berhane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Kidney biopsy in patients with diabetes mellitus
D. G. Haider et al.
CLINICAL NEPHROLOGY (2011)
Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease
Tae Ik Chang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
PKCα Mediates β-Arrestin2-dependent Nephrin Endocytosis in Hyperglycemia
Ivo Quack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Markus Goedel et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
Sufyan G. Sayyed et al.
KIDNEY INTERNATIONAL (2011)
Renal biopsy in type 2 diabetes: Timing of complications and evaluating of safety in Chinese patients
Pei-Pei Zhang et al.
NEPHROLOGY (2011)
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Nondiabetic Renal Disease in Type 2 Diabetic Patients: A Review of our Experience in 220 Cases
Huixin Bi et al.
RENAL FAILURE (2011)
Clinical versus histological diagnosis of diabetic nephropathy-is renal biopsy required in type 2 diabetic patients with renal disease?
G. Biesenbach et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Gavin I. Welsh et al.
CELL METABOLISM (2010)
Prevalence of non-diabetic renal disease in patients with type 2 diabetes
Shan Mou et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Pathologic Classification of Diabetic Nephropathy
Thijs W. Cohen Tervaert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Podocytic PKC-Alpha Is Regulated in Murine and Human Diabetes and Mediates Nephrin Endocytosis
Irini Tossidou et al.
PLOS ONE (2010)
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Jurg Tschopp et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions
Amal Abdel Ghani et al.
ANNALS OF SAUDI MEDICINE (2009)
Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease
Y. -L. Lin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Mouse Models of Diabetic Nephropathy
Frank C. Brosius et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
Assam El-Osta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Microscopic hematuria and diabetic glomerulosclerosis - Clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria
Tetsu Akimoto et al.
NEPHRON CLINICAL PRACTICE (2008)
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
Berend Isermann et al.
NATURE MEDICINE (2007)
Prevalence of nondiabetic renal disease in diabetic patients
Tam T. Pham et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Non-diabetic renal disease in type 2 diabetes mellitus
Sachin S. Soni et al.
NEPHROLOGY (2006)
Impact of diets and nutrients/drugs on early epigenetic programming
Claudine Junien
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo
M Nieuwdorp et al.
DIABETES (2006)
High ambient glucose levels modulates the production of MMP-9 and alpha 5(IV) collagen by cultured podocytes
YL Bai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Podocyte. depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene
BL Wharram et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
A Tone et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
FY Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Gene-nutrient interactions in one-carbon metabolism
S Friso et al.
CURRENT DRUG METABOLISM (2005)
Rapidly progressive renal failure in type 2 diabetes in the tropical environment: A clinico-pathological study
V Moger et al.
RENAL FAILURE (2005)
The Czech registry of renal biopsies.: Occurrence of renal diseases in the years 1994-2000
I Rychlík et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Extracellular matrix metabolism in diabetic nephropathy
RM Mason et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Nephrin expression is reduced in human diabetic nephropathy - Evidence for a distinct role for glycated albumin and angiotensin II
S Doublier et al.
DIABETES (2003)
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
AI Adler et al.
KIDNEY INTERNATIONAL (2003)
Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes?
A Serra et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2002)
Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies
TYH Wong et al.
DIABETES CARE (2002)
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
G Mazzucco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Retinopathy, hematuria, and diabetic nephropathy
H Izzedine et al.
NEPHRON (2001)
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients
HH Parving et al.
KIDNEY INTERNATIONAL (2001)
Prevalence of non-diabetic renal disease among African-American patients with type II diabetes mellitus
CM Nzerue et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2000)
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy
PK Christensen et al.
KIDNEY INTERNATIONAL (2000)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
